ARCHIVES

In Brief: Raub To Leave NIH For Science Office; Douros Dead At 60; ‘NEJM’ To Publish Aspirin Study

This article is from The Cancer Letter archive.

Vol. 17 No. 46 | November 29, 1991

Download PDF Visit The Full Archive

Related Articles

PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III

November 28, 2014

Additional DCE Contract Concepts

November 16, 1984

FDA Staff Failed To Explain Approval Standards, Correct Misconceptions.

April 13, 2007

Gallo Breakthrough On AIDS Etiology To Be Reported Soon

April 20, 1984

NCI Advisors Approve $100M Set Aside for Physical Sciences-Oncology Centers.

December 12, 2008

President’s Cancer Panel Lists Recommendations For Improving Quality Of Cancer Care

April 9, 1999